PP

Priti Pankaj Salunke

Active Director Director DIN 11459321
DIN 11459321 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Priti Pankaj Salunke

Data last updated:

Priti Pankaj Salunke is a Director at Rationale Pharma Private Limited (since 2026).

DIN 11459321
Primary Designation Director
First Appointment 07 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rationale Pharma Private Limited U46497PN2026PTC250406
Director07 Jan 20262026Active

Directorship timeline

Open interactive timeline →
Rationale Pharma Private Limited
Premium access

Shareholding and investment profile for Priti Pankaj Salunke

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priti Pankaj Salunke

Priti Pankaj Salunke currently holds 1 directorship: Rationale Pharma Private Limited (Director, since 07 Jan 2026).

Priti Pankaj Salunke was first appointed on 07 Jan 2026 as Director at Rationale Pharma Private Limited.

The current boards of Priti Pankaj Salunke's companies include Archita Anant Patil (Rationale Pharma Private Limited), Bhushan Manohar Deore (Rationale Pharma Private Limited), Priyanka Sudarshan Patil (Rationale Pharma Private Limited), Sharda Dhananjay Ture (Rationale Pharma Private Limited), Sonali Rahul Ambegaonkar (Rationale Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available